Evidence map›Paper›PMID 25016221›Full record

ArticleJournal of hepatology2014

Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology.

Sílvia Vilarinho, Murim Choi, Dhanpat Jain, Ajay Malhotra, Sanjay Kulkarni, Dinesh Pashankar, Uma Phatak, Mohini Patel, Allen Bale, Shrikant Mane and 2 more

Abstract readCase Reports
In one paragraph

Article in Journal of hepatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 57 citations in OpenAlex.

  1. Genetic testing in liver diseases: Clinical applications.JHEP reports : innovation in hepatology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetics of liver disease in adults.Hepatology communications · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Genomic medicine for liver disease.Hepatology (Baltimore, Md.) · 2022
    Review
  11. Article
  12. Undiagnosed liver diseases.Translational gastroenterology and hepatology · 2021
    Review
  13. Article
  14. Article
  15. Exome Sequencing in Clinical Hepatology.Hepatology (Baltimore, Md.) · 2019
    Review
  16. Article
  17. Article
  18. Recessive Mutations inHepatology communications · 2019
    Article
  19. Article
  20. ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Sílvia VilarinhoDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States; Digestive Diseases Section, Yale University School of Medicine, New Haven, CT, United States; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, United States; Department of Genetics, Yale University School of Medicine, New Haven, CT, United States.
Murim ChoiHoward Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, United States; Department of Genetics, Yale University School of Medicine, New Haven, CT, United States; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Dhanpat JainDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States; Digestive Diseases Section, Yale University School of Medicine, New Haven, CT, United States; Department of Pathology, Yale University School of Medicine, New Haven, CT, United States.
Ajay MalhotraDepartment of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT, United States.
Sanjay KulkarniDepartment of Surgery, Section of Transplantation and Immunology, Yale University School of Medicine, New Haven, CT, United States.
Dinesh PashankarDepartment of Pediatrics, Gastroenterology-Hepatology Section, Yale University School of Medicine, New Haven, CT, United States.
Uma PhatakDepartment of Pediatrics, Gastroenterology-Hepatology Section, Yale University School of Medicine, New Haven, CT, United States.
Mohini PatelDepartment of Pediatrics, Gastroenterology-Hepatology Section, Yale University School of Medicine, New Haven, CT, United States.
Allen BaleDepartment of Genetics, Yale University School of Medicine, New Haven, CT, United States.
Shrikant ManeDepartment of Genetics, Yale University School of Medicine, New Haven, CT, United States; Yale Center for Mendelian Genomics, Yale University School of Medicine, New Haven, CT, United States.
Richard P LiftonDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, United States; Department of Genetics, Yale University School of Medicine, New Haven, CT, United States; Yale Center for Mendelian Genomics, Yale University School of Medicine, New Haven, CT, United States.
Pramod K MistryDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States; Digestive Diseases Section, Yale University School of Medicine, New Haven, CT, United States; Department of Pediatrics, Gastroenterology-Hepatology Section, Yale University School of Medicine, New Haven, CT, United States. Electronic address: pramod.mistry@yale.edu.
Yale University · USHoward Hughes Medical Institute · US

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI DAVID L RIMM · 1985 to 2026
$85.0M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Yale Center for Mendelian GenomicsUM1HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2016 to 2020
$14.8M
Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
POR In Inherited Metabolic Liver DiseasesK24DK066306 · NIDDK · YALE UNIVERSITY · PI MISTRY, PRAMOD K · 2005 to 2009
$738k
NCATS NIH HHS UL1 TR000142NHGRI NIH HHS U04HG.006504NIDDK NIH HHS K24 DK066306
6 · The paper itself

Abstract

BACKGROUND &

aimsIn children with liver failure, as many as half remain of indeterminate aetiology. This hinders timely consideration of optimal treatment options. We posit that a significant subset of these children harbour known inherited metabolic liver diseases with atypical presentation or novel inborn errors of metabolism. We investigated the utility of whole-exome sequencing in three children with advanced liver disease of indeterminate aetiology.

methodsPatient 1 was a 10 year-old female diagnosed with Wilson disease but no detectable ATP7B mutations, and decompensated liver cirrhosis who underwent liver transplant and subsequently developed onset of neurodegenerative disease. Patient 2 was a full-term 2 day-old male with fatal acute liver failure of indeterminate aetiology. Patient 3 was an 8 year-old female with progressive syndromic cholestasis of unknown aetiology since age 3 months.

resultsUnbiased whole-exome sequencing of germline DNA revealed homozygous mutations in MPV17 and SERAC1 as the disease causing genes in patient 1 and 2, respectively. This is the first demonstration of SERAC1 loss-of-function associated fatal acute liver failure. Patient 1 expands the phenotypic spectrum of the MPV17-related hepatocerebral mitochondrial DNA depletion syndrome. Patient 3 was found to have syndromic cholestasis due to bi-allelic NOTCH2 mutations.

conclusionsOur findings validate the application of whole-exome sequencing in the diagnosis and management of children with advanced liver disease of indeterminate aetiology, with the potential to enhance optimal selection of treatment options and adequate counselling of families. Moreover, whole-exome sequencing revealed a hitherto unrecognized phenotypic spectrum of inherited metabolic liver diseases.

Indexed as

ExomeAmino Acid SequenceBase SequenceCarboxylic Ester HydrolasesChildCholestasisDNA Mutational AnalysisEnd Stage Liver DiseaseFatal OutcomeFemaleGenes, RecessiveHepatolenticular DegenerationHeterozygoteHomozygoteHumansInfant, NewbornCarboxylic Ester HydrolasesMembrane ProteinsMitochondrial ProteinsMPV17 protein, humanNOTCH2 protein, humanReceptor, Notch2RNA Splice SitesSERAC1 protein, humanGenetic diagnosisGermline mutationsInherited metabolic liver diseasesLiver failure of indeterminate aetiologyWhole-exome sequencing

Identifiers

PMID25016221
PMCPMC4203706
OpenAlexW2166221636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.